Search

Medpace Holdings Inc

Open

SectorHealthcare

620.79 0.98

Overview

Share price change

24h

Current

Min

610.22

Max

618.87

Key metrics

By Trading Economics

Income

-2.5M

121M

Sales

727K

707M

P/E

Sector Avg

36.377

48.735

EPS

4.25

Profit margin

17.158

Employees

6,500

EBITDA

-6.9M

148M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

-1.03% downside

Dividends

By Acuity

Next Earnings

21 Oct 2026

Market Stats

By TradingEconomics

Market Cap

2.2B

17B

Previous open

619.81

Previous close

620.79

Medpace Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 Oct 2026, 20:07 UTC

Medpace Holdings Inc shares are declining, finishing significantly lower since Thursday's close, despite a slight recovery earlier in the session.

15 Oct 2026, 20:07 UTC

Social Media
Correlated Moves

Medpace Holdings Inc shares advanced during Thursday's session, supported by a maintained Buy rating on Thermo Fisher Scientific Inc and strong user commentary on performance.

14 Oct 2026, 20:07 UTC

Medpace Holdings Inc shares are advancing, following an early surge that marked its highest cumulative return, despite some retracement during Wednesday's trading session.

12 Oct 2026, 19:56 UTC

Medpace Holdings Inc is trading higher, having gained traction since Friday and currently positioned above its 20-day moving average.

9 Oct 2026, 20:06 UTC

Medpace Holdings Inc is advancing, benefiting from broader market gains since Thursday, despite pulling back slightly from an earlier session peak.

8 Oct 2026, 21:40 UTC

Medpace Holdings Inc is trading lower in after-market hours, continuing a decline since Thursday's close and indicating ongoing weakness below its 20-day moving average.

6 Oct 2026, 20:00 UTC

Correlated Moves
News

Medpace Holdings Inc shares fell amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

5 Oct 2026, 20:01 UTC

Correlated Moves

Charles River Laboratories is sharply higher after a positive earnings report, while Medpace Holdings is also advancing, despite earlier pulling back from a session high.

1 Oct 2026, 20:02 UTC

Correlated Moves

Medpace Holdings Inc shares fell amid a broader market decline, reversing the recent trend of higher daily closes since Wednesday's close.

30 Sept 2026, 19:35 UTC

News

UBS upgraded Medpace Holdings Inc to Neutral with a price target of $673, as shares trade higher amid strong historical performance despite recent insider selling.

25 Sept 2026, 20:07 UTC

Correlated Moves

Medpace Holdings Inc shares fell, reflecting a decline from Thursday's close, amid sympathy with Thermo Fisher Scientific Inc, which is also down.

24 Sept 2026, 20:07 UTC

Correlated Moves
News

Medpace shares are modestly higher as President and CEO August J. Troendle sold 70.9k shares for about $44.43 million, following strong revenue growth.

23 Sept 2026, 20:01 UTC

Correlated Moves

Medpace Holdings Inc shares fell sharply on Wednesday, aligning with a decline in Charles River Laboratories, despite remaining above its 20-day moving average.

22 Sept 2026, 23:01 UTC

Medpace Holdings Inc is rising in after-market trading, continuing a trend above its 20-day moving average and closing higher for three consecutive sessions.

15 Sept 2026, 20:01 UTC

Medpace Holdings Inc. is trading higher today despite negative broader market sentiment following a significant drop in the NY Empire State Manufacturing Index.

11 Sept 2026, 20:08 UTC

Medpace Holdings Inc. is advancing during Friday's session, having reached a session high earlier, though it has since pulled back from that peak.

3 Sept 2026, 20:07 UTC

News

Medpace Holdings shares are declining amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2 Sept 2026, 20:08 UTC

Medpace Holdings Inc. is rising amid broader gains in the Life Sciences Tools & Services sector, despite no specific company news driving the movement.

1 Sept 2026, 20:08 UTC

Correlated Moves
News

Medpace Holdings Inc shares are lower amid insider selling and an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing.

31 Aug 2026, 20:07 UTC

Correlated Moves

Medpace Holdings shares are lower today, reflecting broader sector dynamics and rising interest rate expectations following the Jackson Hole Economic Symposium.

26 Aug 2026, 20:08 UTC

Medpace Holdings Inc. shares are higher today, continuing an upward trend since Tuesday's close. The stock remains above its 20-day moving average.

25 Aug 2026, 20:07 UTC

News

Shares of Medpace Holdings Inc are trading lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing by company officers.

20 Aug 2026, 19:41 UTC

Social Media

Medpace Holdings Inc. is rising amid strong gains in the Life Sciences Tools & Services sector and positive sentiment surrounding biotech investments.

19 Aug 2026, 20:02 UTC

Medpace Holdings Inc. shares are higher, driven by a significant advance in the Life Sciences Tools & Services sub-sector amid a strong market session.

17 Aug 2026, 20:02 UTC

News

Medpace Holdings Inc. shares are higher following a Barron's report suggesting significant upside potential and robust Q2 results exceeding analyst expectations.

14 Aug 2026, 19:36 UTC

Medpace Holdings Inc shares are lower amid broader market sentiment following a Commerce Department report showing a decline in retail sales for July.

13 Aug 2026, 19:56 UTC

News

Medpace Holdings shares are lower as CEO August J. Troendle sold 23,144 shares valued at $13.98 million, raising investor concerns about future performance.

7 Aug 2026, 19:16 UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

3 Aug 2026, 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

30 Jul 2026, 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

-1.03% downside

12 Months Forecast

Average 612.1 USD  -1.03%

High 700 USD

Low 492 USD

Based on 12 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

12 ratings

2

Buy

10

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat